ESMO Afr frica, , 2019 NHL &HIV Case Presentation 16 February - - PowerPoint PPT Presentation

esmo afr frica 2019
SMART_READER_LITE
LIVE PREVIEW

ESMO Afr frica, , 2019 NHL &HIV Case Presentation 16 February - - PowerPoint PPT Presentation

ESMO Afr frica, , 2019 NHL &HIV Case Presentation 16 February ry 2 2019, Cape Town SA Dr. A.M. Nyakabau Consultant Oncologist, Harare Parirenyatwa Hospital College of Health Sciences, Zimbabwe Demographics Mr T.M 32 year old banker


slide-1
SLIDE 1

ESMO Afr frica, , 2019 NHL &HIV Case Presentation 16 February ry 2 2019, Cape Town SA

  • Dr. A.M. Nyakabau

Consultant Oncologist, Harare Parirenyatwa Hospital College of Health Sciences, Zimbabwe

slide-2
SLIDE 2

Demographics

Mr T.M 32 year old banker Married with 2 children (5years; 18 months) Lives in Harare

slide-3
SLIDE 3

Presenting History ry

  • Diagnosed HIV positive June 2013 (discordant couple)
  • July 2013 started on ART (Tenolam-E) & Cotrimoxzole prophylaxis
  • Six months later: Developed painless right groin mass
  • Physician initially attributed the mass to IRIS
  • No history of B symptoms
slide-4
SLIDE 4

Presenting History ry

  • By July 2014 mass enlarged significantly
  • Referred to surgeons, biopsy August 2014
  • Oct 2014, oncologist referral then haematologist
  • Further inv & treatment by haematologist
slide-5
SLIDE 5

Past medical & & Family history ry

  • No history cancer or other chronic illnesses
  • Never previous treatment with chemo/RT
  • No Family history of cancer
  • Does not drink or smoke, banker, married 2 daughters
slide-6
SLIDE 6

Examination fi findings at presentation

  • Stable, apyrexial, ECOG Performance Status 0
  • Approx7cm enlarged firm right groin lymph node mass
  • No lymphadenopathy elsewhere
  • CVS/RS & other systems: normal
slide-7
SLIDE 7

In Investigations (S (Sept 2014)

  • Full blood count
  • Wcc 7,2 Hb 15,2 Plt 379
  • U&E
  • Na 135 K 4.8 U 6 Cr 90
  • LFT
  • Serum Bil 3.2 AST 23 ALT 30 ALP 129 Albumin 46
  • Hep B & C negative
slide-8
SLIDE 8

In Investigations (S (Sept 2014)

  • Serum LDH: 699 U/L (normal 60- 350)
  • Uric Acid: 369 U/l (normal 230-350)
  • Viral load 40 copies/ml
  • CD4 count: 552cells/uL
  • ECHO: Normal heart structure & function, EF 75%
slide-9
SLIDE 9

Histopathology

  • Large cell diffuse Non-Hodgkin's lymphoma with
  • Large atypical lymphoid cells with rounded nuclei
  • Frequent mitosis
  • Prominent apoptosis
  • Partial necrosis
  • Immunohistochemistry: CD20 positive
  • Bone marrow- no evidence of malignancy
slide-10
SLIDE 10

Staging CT Scan chest, abdomen + pelvis

  • Large lobulated mass in the inguino-femoral region
  • Approx. 7cm x 7cm
  • Infiltrating the right pectineus and sartorius muscles
  • Enlarged left internal iliac lymph nodes
  • Urinary bladder, ureters & kidneys normal
  • Normal liver, chest & bones
slide-11
SLIDE 11

In International Prognostic In Index

SCORE Age <60 years LDH level elevated 1 ECOG Score Disease stage <3 Extranodal disease sites <2

TOTAL 1 (LOW RISK)

slide-12
SLIDE 12

Diagnosis

1. Diffuse Large Cell Non-Hodgkin's Lymphoma

  • STAGE I/II (Ann Arbor)
  • IPI low risk

2. HIV positive and no features of AIDS

slide-13
SLIDE 13

Treatment options considered

1. Immunochemotherapy Plus IFRT

  • Rituximab plus CHOP (3 cycles) then Involved Field External

Beam Radiotherapy (IFRT)

2. Immunochemotherapy alone

  • Rituximab plus CHOP (6 cycles)

3. Chemotherapy alone

  • CHOP
slide-14
SLIDE 14

Treatment given to Mr TM

  • R-CHOP three weekly up to 6 cycles
  • Rituximab 375mg/m2
  • Cyclophosphamide 750mg/m2
  • Doxorubicin 50mg/m2
  • Prednisolone 100mg PO Od x 5 days
slide-15
SLIDE 15

Treatment Details

  • From November 2014- February 2015
  • Tolerated therapy well; had alopecia at the 5th cycle
  • No treatment delays
  • Declined referral back to oncology for RT
slide-16
SLIDE 16

Progress to date

  • In remission for 3 years post-treatment
  • Being followed up by a primary care physician
  • HIV infection well controlled
  • CD4 count – 630cell/uL; VL undetectable
  • 2nd child 18/12months,Wife & two daughters HIV negative
slide-17
SLIDE 17

Discussion Points

Mr T.M. was treated privately on Health Insurance Public pts cannot afford Immunochemotherapy Antenatal HIV diagnosis by gynecologist-good clinical practice Presentation post- HIV treatment –IRIS Optimum waiting period post-chemo to father children?

slide-18
SLIDE 18

Discussion

  • CT scan enlarged internal iliac nodes ? Tumour/

Inflammation ? PET/CT scan value

  • What is the role of RT role after Immunochemotherapy ?
  • How well tolerated is R-CHOP in HIV positive patients
  • What is the recommended follow up protocol?
slide-19
SLIDE 19

Zimbabwe Cancer Facts Total :7 165 (2015)

New Cases Cancer Deaths

Chokunonga E, et al, Zimbabwe Cancer Registry 2015 Annual Report

slide-20
SLIDE 20

Acknowledgements

  • Patient & family
  • Parirenyatwa hospital Colleagues & staff
slide-21
SLIDE 21

Thank You